Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 5/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
| ▸ | MC4R | P32245 | 1/20 | 0.44 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.39 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.39 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSH | P09668 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29801712 | 0.93 | ACE (0.48) | ACEOPRK1MC4RNTSR2NTSR1 | |
| SCHEMBL29802052 | 0.91 | ACE (0.48) | ACEOPRK1MC4RC5AR1CTSL | |
| SCHEMBL30205299 | 0.88 | MC4R (0.48) | MC4RC5AR1CTSLCTSHCTSS | |
| SCHEMBL29590456 | 0.86 | TRHR (0.41) | ACE | |
| SCHEMBL29630526 | 0.86 | TRHR (0.41) | ACE | |
| SCHEMBL29801886 | 0.86 | OPRM1 (0.47) | ACEOPRK1C5AR1CTSLCTSH | |
| SCHEMBL29630596 | 0.84 | MEN1 (0.43) | ACEOPRK1MC4R | |
| SCHEMBL31467764 | 0.84 | MC4R (0.50) | ACEOPRK1MC4RC5AR1CTSL | |
| SCHEMBL29802279 | 0.83 | NTSR2 (0.47) | NTSR2NTSR1C5AR1 | |
| SCHEMBL29630670 | 0.82 | TRHR (0.42) | ACEOPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022188878-A1 | MULTIFUNCTIONAL POLYPEPTIDE AND APPLICATION THEREOF IN FIELD OF MEDICINES | 武汉英纳氏药业有限公司 | 2022-09-15 | — | — | WO | disclosed |